Human urinary kallindinogenase therapy for acute ischemic stroke according to Chinese ischemic stroke subclassification: Clinical efficacy and risk factors.

Chen, Si-Qia; Mao, Dong-Yang; Wei, Dun-Can; He, Wen-Zhen

Chen, Si-Qia; Mao, Dong-Yang; Wei, Dun-Can; He, Wen-Zhen.

Afiliación

Chen SQ; Department of Neurology, First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Mao DY; Clinical Pharmacy, First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Wei DC; Department of Pharmacy, First Affiliated Hospital of Shantou University Medical College, Shantou, China.
He WZ; Department of Neurology, First Affiliated Hospital of Shantou University Medical College, Shantou, China.

Brain Behav ; 10(1): e01461, 2020 01.

Article en En | MEDLINE | ID: mdl-31793238

Asunto(s)

Accidente Cerebrovascular Isquémico/tratamiento farmacológico; Calicreínas/uso terapéutico; Anciano; Femenino; Humanos; Masculino; Persona de Mediana Edad; Estudios Retrospectivos; Factores de Riesgo; Resultado del Tratamiento

Palabras clave

Chinese ischemic stroke subclassification; acute ischemic stroke; homocysteine; human urinary kallidinogenase; large artery atherosclerosis; risk factor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calicreínas / Accidente Cerebrovascular Isquémico Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Brain Behav Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google